Daewoong Pharm seeks bigger market share of Naramig

Published: 2006-10-31 06:57:00
Updated: 2006-10-31 06:57:00
Daewoong Pharm plans to expand its share of Naramig tablets (naratriptan) as one of the leading items in the local anti-migraine drug market.

Naratriptan is a triptan drug developed by GSK and is used for the treatment of migraine headaches.

Last month, Yoon Jae-seung, vice president of Dae...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.